MIND vs REGN · P/E 31, rev $46.9M vs P/E 14, rev $14.34B
Mind Technology Inc (MIND) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Mind Technology Inc (MIND) is a scientific & technical instruments company listed on NASDAQ.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported MIND revenue for 2025-01-31 was $46.9M. Net income was $5.1M. Revenue was up 28.4% from 2024-01-31 to 2025-01-31. MIND currently screens at market cap $45.6M and trailing P/E 31.4.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
MIND currently screens at market cap $45.6M and trailing P/E 31.4. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the MIND and REGN stock pages for the full models.
Not investment advice.